The FDA's decision creates "a lot of confusion for patients, and now they suddenly have to start looking for branded medications," said Dae Lee, a New Jersey attorney who represents pharmacies
Retatrutide continues to be evaluated in additional Phase 3 studies across obesity and obesity-related conditions, including knee osteoarthritis pain, moderate-to-severe obstructive sleep apnea, chronic low back pain, cardiovascular and renal outcomes, and metabolic dysfunction-associated steatotic liver disease (MASLD)
Consistent site rotation prevents lipohypertrophy entirely
Ask your healthcare provider or pharmacist for a list of these medicines if you are not sure
Anyone considering IV therapy should undergo screening for conditions like glucose 6 phosphate dehydrogenase (G6PD) deficiency, kidney problems, and iron overload
Even worse, GLP-1s were discontinued without notice, leaving patients paying premium prices for outdated or limited treatments